Bifogade filer
PDF
Kurs & Likviditet
+16,36%
|
311 MSEK
Kursutveckling och likviditet under dagen för detta pressmeddelande
Kalender
| 2025-01-30 | Bokslutskommuniké 2024 |
| 2024-10-24 | Kvartalsrapport 2024-Q3 |
| 2024-07-17 | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | Ordinarie utdelning VITR 1.00 SEK |
| 2024-04-25 | Årsstämma 2024 |
| 2024-04-18 | Kvartalsrapport 2024-Q1 |
| 2024-02-02 | Bokslutskommuniké 2023 |
| 2023-10-27 | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | Ordinarie utdelning VITR 0.85 SEK |
| 2023-04-27 | Årsstämma 2023 |
| 2023-04-21 | Kvartalsrapport 2023-Q1 |
| 2023-02-02 | Bokslutskommuniké 2022 |
| 2022-10-27 | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | Ordinarie utdelning VITR 0.80 SEK |
| 2022-04-27 | Årsstämma 2022 |
| 2022-04-22 | Kvartalsrapport 2022-Q1 |
| 2022-02-16 | Bokslutskommuniké 2021 |
| 2021-10-29 | Kvartalsrapport 2021-Q3 |
| 2021-10-20 | Extra Bolagsstämma 2021 |
| 2021-07-15 | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | Ordinarie utdelning VITR 0.80 SEK |
| 2021-04-28 | Årsstämma 2021 |
| 2021-04-22 | Kvartalsrapport 2021-Q1 |
| 2021-02-10 | Bokslutskommuniké 2020 |
| 2020-11-06 | Kvartalsrapport 2020-Q3 |
| 2020-07-13 | Kvartalsrapport 2020-Q2 |
| 2020-06-16 | Ordinarie utdelning VITR 0.00 SEK |
| 2020-06-15 | Årsstämma 2020 |
| 2020-04-23 | Kvartalsrapport 2020-Q1 |
| 2020-02-06 | Bokslutskommuniké 2019 |
| 2019-11-06 | Kvartalsrapport 2019-Q3 |
| 2019-07-12 | Kvartalsrapport 2019-Q2 |
| 2019-05-03 | Ordinarie utdelning VITR 0.85 SEK |
| 2019-05-02 | Årsstämma 2019 |
| 2019-04-23 | Kvartalsrapport 2019-Q1 |
| 2019-02-08 | Bokslutskommuniké 2018 |
| 2018-11-06 | Kvartalsrapport 2018-Q3 |
| 2018-07-13 | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | Split VITR 1:5 |
| 2018-04-27 | Ordinarie utdelning VITR 3.70 SEK |
| 2018-04-26 | Årsstämma 2018 |
| 2018-04-24 | Kvartalsrapport 2018-Q1 |
| 2018-02-08 | Bokslutskommuniké 2017 |
| 2017-11-02 | Kvartalsrapport 2017-Q3 |
| 2017-07-14 | Kvartalsrapport 2017-Q2 |
| 2017-04-28 | Ordinarie utdelning VITR 2.60 SEK |
| 2017-04-27 | Årsstämma 2017 |
| 2017-04-25 | Kvartalsrapport 2017-Q1 |
| 2017-02-09 | Bokslutskommuniké 2016 |
| 2016-11-03 | Kvartalsrapport 2016-Q3 |
| 2016-09-20 | Kapitalmarknadsdag 2016 |
| 2016-07-15 | Kvartalsrapport 2016-Q2 |
| 2016-04-29 | Ordinarie utdelning VITR 2.40 SEK |
| 2016-04-28 | Årsstämma 2016 |
| 2016-04-26 | Kvartalsrapport 2016-Q1 |
| 2016-02-05 | Bokslutskommuniké 2015 |
| 2015-11-05 | Kvartalsrapport 2015-Q3 |
| 2015-07-14 | Kvartalsrapport 2015-Q2 |
| 2015-05-06 | Ordinarie utdelning VITR 1.50 SEK |
| 2015-05-05 | Årsstämma 2015 |
| 2015-04-28 | Kvartalsrapport 2015-Q1 |
| 2015-02-06 | Bokslutskommuniké 2014 |
| 2014-11-06 | Kvartalsrapport 2014-Q3 |
| 2014-11-06 | Analytiker möte 2014 |
| 2014-11-06 | Kapitalmarknadsdag 2014 |
| 2014-07-11 | Kvartalsrapport 2014-Q2 |
| 2014-05-06 | Ordinarie utdelning VITR 1.00 SEK |
| 2014-05-05 | Årsstämma 2014 |
| 2014-04-23 | Kvartalsrapport 2014-Q1 |
| 2014-02-06 | Bokslutskommuniké 2013 |
| 2013-11-11 | Kapitalmarknadsdag 2013 |
| 2013-11-07 | Kvartalsrapport 2013-Q3 |
| 2013-11-07 | Analytiker möte 2013 |
| 2013-07-12 | Kvartalsrapport 2013-Q2 |
| 2013-04-30 | Ordinarie utdelning VITR 0.60 SEK |
| 2013-04-29 | Årsstämma 2013 |
| 2013-04-19 | Kvartalsrapport 2013-Q1 |
| 2013-03-13 | 15-7 2013 |
| 2013-02-07 | Bokslutskommuniké 2012 |
| 2012-11-01 | Analytiker möte 2012 |
| 2012-11-01 | Kvartalsrapport 2012-Q3 |
| 2012-09-24 | Extra Bolagsstämma 2012 |
| 2012-07-13 | Kvartalsrapport 2012-Q2 |
| 2012-04-20 | Ordinarie utdelning VITR 0.60 SEK |
| 2012-04-19 | Kvartalsrapport 2012-Q1 |
| 2012-04-19 | Årsstämma 2012 |
| 2012-02-07 | Bokslutskommuniké 2011 |
| 2011-10-27 | Kvartalsrapport 2011-Q3 |
| 2011-07-14 | Kvartalsrapport 2011-Q2 |
| 2011-04-28 | Ordinarie utdelning VITR 0.60 SEK |
| 2011-04-27 | Kvartalsrapport 2011-Q1 |
| 2011-04-27 | Årsstämma 2011 |
| 2011-02-09 | Bokslutskommuniké 2010 |
| 2010-11-02 | Kvartalsrapport 2010-Q3 |
| 2010-07-15 | Kvartalsrapport 2010-Q2 |
| 2010-04-27 | Kvartalsrapport 2010-Q1 |
| 2010-04-27 | Ordinarie utdelning VITR 0.50 SEK |
| 2010-04-26 | Årsstämma 2010 |
| 2010-02-05 | Bokslutskommuniké 2009 |
| 2009-11-03 | Kvartalsrapport 2009-Q3 |
| 2009-07-15 | Kvartalsrapport 2009-Q2 |
| 2009-04-28 | Ordinarie utdelning VITR 0.40 SEK |
| 2009-04-27 | Kvartalsrapport 2009-Q1 |
| 2009-04-27 | Årsstämma 1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2023-02-02 08:00:00
Fourth quarter
- Sales of SEK 855 (514) million, corresponding to an increase of 66% in SEK, whereof organic growth 11%, acquired growth 37% and currency effect 18%. Sales pro forma increased 9% in local currencies (adjusted for business related to Covid-19 tests and divested business).
- Consumables increased sales by 23% in SEK, Technologies increased by 36% in SEK, and Genetic Services contributed acquired sales of SEK 192 million.
- Including the acquisition we have strong growth in all market regions, Americas 81%, EMEA 31%, Japan Pacific 56% and Asia 32% in local currencies.
- Organic growth in local currency (pro forma, adjusted for business related to Covid-19 tests) was in Japan Pacific 24%, Asia 15%, EMEA 6%, and Americas 1%.
- Operating income before depreciation and amortisation (EBITDA) was SEK 273 (85) million, corresponding to a margin of 31.9% (16.5%) (pro forma 27.8%). EBITDA per share increased by 196% to SEK 2.02.
- Net income was SEK 73 (34) million, resulting in earnings per share of SEK 0.55 (0.26).
- Sales of SEK 3,234 (1,681) million, corresponding to an increase of 92% in SEK, whereof organic growth 10%, acquired growth 65% and currency effect 18%. Sales pro forma increased 10% in local currencies (adjusted for business related to Covid-19 tests and divested business).
- Consumables increased sales by 23% in SEK, Technologies by 16% in SEK, and Genetic Services contributed acquired sales of SEK 1,085 million.
- Including the acquisition we have strong growth in all market regions. Americas 177%, EMEA 48%, Japan Pacific 59% and Asia 38% in local currencies.
- Organic growth in local currency (pro forma, adjusted for business related to Covid-19 tests) was in Japan Pacific 19%, Asia 16%, EMEA 3%, and Americas 8%.
- Operating income before depreciation and amortisation (EBITDA) was SEK 1,050 (544) million, corresponding to a margin of 32.5% (32.4%) (pro forma 32.2%). EBITDA per share increased 63% to SEK 7.75.
- Net income was SEK 394 (344) million, resulting in earnings per share of SEK 2.91 (2.97).
- Net debt/EBITDA 1.5 (3.2) rolling 12 months.
- Bronwyn Brophy is appointed as new CEO of Vitrolife AB (publ). She will join the company at the latest of 1 August 2023.
- The Chairman of the Board, Jón Sigurdsson will assume the position as interim CEO from 1 April 2023.
- Board member, Henrik Blomquist, will be the Chairman of the board from 1 April 2023 until the annual general meeting on 27 April 2023.
- Current CEO, Thomas Axelsson, will leave his position as CEO, from 31 March 2023.
- The Board proposes a dividend of SEK 0.85 (0.80) per share, corresponding to SEK 115 (108) million.
Contact persons:
Thomas Axelsson, CEO, phone: +46 31 721 80 01
Patrik Tolf, CFO, phone: +46 31 766 90 21
This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 8.00 am CET on February 2, 2023.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.